News
As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
In his first town hall since voting in favor of Donald Trump’s “big, beautiful bill,” Nebraska Representative Mike Flood had ...
Jeffrey Epstein’s convicted accomplice revealed something interesting about her communication with the Trump administration.
Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
16h
AlterNet on MSN'Hidden hand': MAGA Republicans slam Laura Loomer as a Big Pharma 'plant'Bulwark reporter Will Sommer reports MAGA influencer Laura Loomer is drawing criticism from MAGA members who claim she’s ...
From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
President Trump's executive order to "identify and take appropriate action to correct past misconduct by the Federal Government related to censorship of protected speech" is good enough, DOJ tells ...
Extend transfection complex formation time by up to 3 hours, reduce complex volume by >50% and maintain high titers and full ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results